These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
735 related items for PubMed ID: 31840939
41. [Research of miR-29a on TGF-β1/Smad3 pathway in pulmonary fibrosis induced by neodymium oxide]. Yun YD, Wang SH. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Jan 20; 42(1):10-15. PubMed ID: 38311943 [Abstract] [Full Text] [Related]
42. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts. Li YJ, Azuma A, Usuki J, Abe S, Matsuda K, Sunazuka T, Shimizu T, Hirata Y, Inagaki H, Kawada T, Takahashi S, Kudoh S, Omura S. Respir Res; 2006 Jan 27; 7(1):16. PubMed ID: 16438734 [Abstract] [Full Text] [Related]
43. Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma. Aung WW, Wang C, Xibei J, Horii M, Mizumaki K, Kano M, Okamura A, Kobayashi T, Matsushita T. J Dermatol Sci; 2021 Mar 27; 101(3):174-184. PubMed ID: 33451905 [Abstract] [Full Text] [Related]
44. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis. Meng M, Tan J, Chen W, Du Q, Xie B, Wang N, Zhu H, Wang K. Front Immunol; 2019 Mar 27; 10():1861. PubMed ID: 31481954 [Abstract] [Full Text] [Related]
45. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways. Lv Q, Wang J, Xu C, Huang X, Ruan Z, Dai Y. Mol Med; 2020 May 24; 26(1):49. PubMed ID: 32448163 [Abstract] [Full Text] [Related]
46. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice. Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH. Int Immunopharmacol; 2014 Oct 24; 22(2):498-504. PubMed ID: 25111852 [Abstract] [Full Text] [Related]
47. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions. Mathian A, Parizot C, Dorgham K, Trad S, Arnaud L, Larsen M, Miyara M, Hié M, Piette JC, Frances C, Yssel H, Amoura Z, Gorochov G. Ann Rheum Dis; 2012 Jul 24; 71(7):1227-34. PubMed ID: 22696687 [Abstract] [Full Text] [Related]
49. Thalidomide has a therapeutic effect on interstitial lung fibrosis: evidence from in vitro and in vivo studies. Zhao L, Xiao K, Wang H, Wang Z, Sun L, Zhang F, Zhang X, Tang F, He W. Clin Exp Immunol; 2009 Aug 24; 157(2):310-5. PubMed ID: 19604271 [Abstract] [Full Text] [Related]
50. [THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS]. Rimar D, Slobodin G, Rosner I, Rozenbaum M, Kaly L, Boulman N, Jiries N, Awisat A, Vadasz Z. Harefuah; 2017 Jul 24; 156(7):418-421. PubMed ID: 28786275 [Abstract] [Full Text] [Related]
51. Effect of Renshen Pingfei Decoction, a traditional Chinese prescription, on IPF induced by Bleomycin in rats and regulation of TGF-β1/Smad3. Chen F, Wang PL, Fan XS, Yu JH, Zhu Y, Zhu ZH. J Ethnopharmacol; 2016 Jun 20; 186():289-297. PubMed ID: 27013092 [Abstract] [Full Text] [Related]
52. Anti-fibrotic effect of thalidomide through inhibiting TGF-beta-induced ERK1/2 pathways in bleomycin-induced lung fibrosis in mice. Choe JY, Jung HJ, Park KY, Kum YS, Song GG, Hyun DS, Park SH, Kim SK. Inflamm Res; 2010 Mar 20; 59(3):177-88. PubMed ID: 19757088 [Abstract] [Full Text] [Related]
53. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats. Xu L, Li LC, Zhao P, Qi LW, Li P, Gao J, Fei GH. J Pharm Pharmacol; 2014 Dec 20; 66(12):1786-95. PubMed ID: 25209833 [Abstract] [Full Text] [Related]
54. Local inhibition of TGF-β1 signaling improves Th17/Treg balance but not joint pathology during experimental arthritis. Aarts J, van Caam A, Chen X, Marijnissen RJ, Helsen MM, Walgreen B, Vitters EL, van de Loo FA, van Lent PL, van der Kraan PM, Koenders MI. Sci Rep; 2022 Feb 24; 12(1):3182. PubMed ID: 35210510 [Abstract] [Full Text] [Related]
55. Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula. Zhao P, Li J, Tian Y, Mao J, Liu X, Feng S, Li J, Bian Q, Ji H, Zhang L. J Ethnopharmacol; 2018 May 10; 217():152-162. PubMed ID: 29454913 [Abstract] [Full Text] [Related]
56. Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats. Chen L, Wang T, Wang X, Sun BB, Li JQ, Liu DS, Zhang SF, Liu L, Xu D, Chen YJ, Wen FQ. Respir Res; 2009 Jun 24; 10(1):55. PubMed ID: 19552800 [Abstract] [Full Text] [Related]
57. [Effects of diterpene phenol extract of Rosmarinus officinalis on TGFbeta1 and mRNA expressions of its signaling pathway molecules in the lung tissue of pulmonary fibrosis rats]. Yang LT, Liu X, Cheng DY, Fang X, Mu M, Hu XB, Nie L. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun 24; 33(6):819-24. PubMed ID: 23980366 [Abstract] [Full Text] [Related]
58. Role of Treg and TH17 cells of the gastric mucosa in children with Helicobacter pylori gastritis. Gil JH, Seo JW, Cho MS, Ahn JH, Sung HY. J Pediatr Gastroenterol Nutr; 2014 Feb 24; 58(2):245-51. PubMed ID: 24121150 [Abstract] [Full Text] [Related]
59. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling. Li N, Feng F, Wu K, Zhang H, Zhang W, Wang W. Biomed Pharmacother; 2019 Nov 24; 119():109387. PubMed ID: 31487583 [Abstract] [Full Text] [Related]